[1. U.S. Department of Health and Human Services: Smoking and Health. A National Status Report. 2nd Edition; Washington DC: DHHS Publication Nr. (CDC) 87-8396 (Revised 02/90), Rockville, Maryland, 1986]Search in Google Scholar
[2. Thielen, A., H. Klus, and L. Müller: Tobacco smoke: unraveling a controversial subject; Exp. Toxicol. Pathol. 60 (2008) 141–156.]Search in Google Scholar
[3. Gupta, P.C., P.R. Murti, and R.B. Bhonsle: Epide-miology of cancer by tobacco products and the signi-ficance of TSNA; Crit. Rev. Toxicol. 26 (1996) 183–198.]Search in Google Scholar
[4. Hoffmann, D. and M.V. Djordjevic: Chemical compo-sition and carcinogenicity of smokeless tobacco; Adv. Dent. Res. 11(1997) 322–329.]Search in Google Scholar
[5. Pöschl, E.: Schnupftabak Lexikon; Pöschl Tabak, Landshut, Germany, 2004, pp. 15–26.]Search in Google Scholar
[6. Kozlowski, S.: Snuff in former Poland [Der Schnupf-tabak im früheren Polen]; Fachl. Mitt. Österr. Tabak-regie II/1 (1902) 20–24.]Search in Google Scholar
[7. Rodu, B. and C. Jansson: Smokeless tobacco and oral cancer: a review of the risks and determinants; Crit. Rev. Oral Biol. Med. 15 (2004) 252–263]Search in Google Scholar
[8. Stepanov, I., J. Jensen, D., Hatsukami, and S.S. Hecht: New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels; Nicotine Tob. Res. 10 (2008) 1773-1782]Search in Google Scholar
[9. Rogozinski, J.: Smokeless tobacco in the Western World 1550–1950; Praeger Publishers, New York, 1990, pp. 42–44.]Search in Google Scholar
[10. McGuirt, W.F. and A. Wray: Oral carcinoma and smokeless tobacco use: a clinical profile. In: Smokeless tobacco or health. An international perspective; US Department of Health and Human Services, Smoking and tobacco control monographs, Vol. 2; NCI Publication No. 93-3461,1993, pp. 91–95.]Search in Google Scholar
[11. Federal Trade Commission: Smokelss Tobacco Report for the years 2002 to 2005.; 2007, (accessed September) http://www2.ftc.gov/reports/tobacco/02-05 smokeless0623105.pdf]Search in Google Scholar
[12. Swedish Match: The Gothiatek Standard (accessed September 2009); www.Swedishmatch.com/en/snus-and-health/our-quality-standard-GothiaTek/GothiaTek-standards.]Search in Google Scholar
[13. Ramström, L.: Snuff: an alternative nicotine delivery system; in: Nicotine and public health, edited by R. Ferrence, J. Slade, R. Room and M. Pope, American Public Health Association, Washington, D.C., pp. 159-–178.]Search in Google Scholar
[14. Statistics Sweden, Unit of Social Wellfare: Alkohol – och tobaksbruk [Use of alcohol and tobacco]. Levnads-förhallanden Report 114, 2007]Search in Google Scholar
[15. Deutsches Krebsforschungszentrum (Hrsg.): Rauchlose Tabakprodukte: Jede Form von Tabak ist gesund-heitschädlich [Smokeless tobacco products: Tobacco in any form is harmful]; Heidelberg, 2006, pp. 25–27.]Search in Google Scholar
[16. Nguyen, H., B. Lynch, and J. Drus: Review of Ariva – A compressed powered tobacco product (Abstract). In: Proceedings of the 3rd International Conference on Smokeless Tobacco, Stockholm, Sweden, Sept. 22–25, 2002,]Search in Google Scholar
[17. Tricker, A.R. and R. Preussmann: The occurrence of N-nitroso compounds in zarda tobacco; Cancer Lett 42 (1988) 113–118]Search in Google Scholar
[18. McNeill, A., R. Bedi, S. Islam, M.N. Alkhatib, and R. West: Levels of toxins in oral tobacco products in the UK; Tob. Control 15 (2006) 64–67.]Search in Google Scholar
[19. Rätsch, C.: Schamanenpflanze Tabak, Band 2, Das Rauchkraut erobert die alte Welt; Nachtschatten-Verlag A.G., 2003, pp 403.]Search in Google Scholar
[20. Harrison, D.F.N.: Snuff – Its use and abuse. Brit. Med. J. 2 (1964) 1649–1651.]Search in Google Scholar
[21. Centre de Cooperation pour les Recherches Scientific relatives au Tabac (CORESTA): Coresta catalogue des Nicotiana; Paris, 1984.]Search in Google Scholar
[22. Preißecker, K.: Das Kapitel “Kau- und Schnupftabak“ im Codex Alimentarius Austriaca [The chapter “Chewing tobacco and Snuff“ of the Codex Alimen-tarius Austriaca]; Fachl. Mitt. Österr. Tabakregie XVII/1–3 (1917) 1–16.]Search in Google Scholar
[23. Bundesrepublik Österreich: Bundesgesetz über das Herstellen und das In-Verkehrbringen von Tabaker-zeugnissen sowie die Werbung für Tabakerzeugnisse und den Nichtraucherschutz (Tabakgesetz), BGBl. Nr. 431/1995, zuletzt geändert durch das Bundesgesetz BGBl. I Nr. 120/2008.]Search in Google Scholar
[24. European Commission: Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2004 on the approximation of the laws, regulations and administrative provisions of the Member States con-cerning the manufacture, presentation and sale of tobacco products. Off. J. Eur. Commun. L194 (2001) 26–34.]Search in Google Scholar
[25. Bundesrepublik Deutschland: “Vorläufiges Tabakgesetz” [Preliminary Tobacco Law] Tabakver-ordnung vom 9. September 1997 (BGBL. I S. 2296), zuletzt geändert durch Artikel 1 der Verordnung vom 21. Dezember 2006 (BGBl. I S. 3365).]Search in Google Scholar
[26. Bundesrepublik Deutschland: Aromenverordnung vom 22. Dezember 1981, Artikel 22 der Verordnung zur Neuordnung lebensmittelrechtlicher Kennzeichnungs-vorschriften in der Fassung vom 2. Mai 2006 (BGBl. I. 1127), zuletzt geändert durch Art. 1 der Verordnung vom 30. September 2008 (BGBl I 1911).]Search in Google Scholar
[27. Bundesrepublik Deutschland: Verordnung über die Zulassung von Zusatzstoffen zu Lebensmitteln zu technologischen Zwecken, Zusatzstoff-Zulassungsverordnung vom 29. Januar 1998 (BGBl I 230, 231), zuletzt geändert durch Art. 3 der Verordnung vom 30. September 2008.]Search in Google Scholar
[28. Bundesrepublik Deutschland: Verordnung über Höchst-mengen an Rückständen von Pflanzenschutz- und Schädlingsbekämpfungsmitteln, Düngemittel und sonstigen Mitteln in und auf Lebensmitteln und Tabakerzeugnissen, Rückstands-Höchstmengenverord-nung – RHmV vom 21. Oktober 1999 (BGBl I S. 2082, ber. 2002 S. 1004), zuletzt geändert durch Art. 3 des Gesetzes vom 29. Juni 2009 (BGBl. I S. 1659).]Search in Google Scholar
[29. Pershagen, G.: Smokeless tobacco; Brit. Med. Bull. 52 (1996) 50–57.10.1093/oxfordjournals.bmb.a011532]Search in Google Scholar
[30. Berka, F.: The essential oils used in tobacco manu-facture [Die bei der Tabakfabrikation in Verwendung stehenden ätherischen Öle] Fachl. Mitt. Österr. Tabak-regie, III/3 (1903) 6–14.]Search in Google Scholar
[31. Berka, F.: A contribution to the knowledge of the aro-matic ingredients used by the k.k. Tobacco Monopoly [Ein Beitrag zur Kenntnis der bei der Tabakregie in Verwendung stehenden aromatischen Ingredienzien] Fachl. Mitt. Österr. Tabakregie, IV/2 (1904) 41–50.]Search in Google Scholar
[32. Department of Health: Permitted additives to tobacco products in the United Kingdom; London, October 2003. http://www.advisorybodies.doh.gov.uk/scoth/technicaladvisorygroup/additiveslist.pdf]Search in Google Scholar
[33. French Republic: Order of the 12th September 1995 relating to additives authorized for use in the manu-facture of tobacco products and of their substitutes. Official J. of the French Republic, October 1st, 1995.]Search in Google Scholar
[34. Swedish Food Regulations. Food Act of 2006, SFS 2006:804.]Search in Google Scholar
[35. Rodgman, A. and T.A. Perfetti: The chemical components of tobacco and tobacco smoke; CRC Press, Boca Raton, Fl, 2009.10.1201/9781420078848]Search in Google Scholar
[36. de Wit, H. and J. Zacny: Abuse potentials of nicotine replacement therapies; CNS Drugs 4 (1995) 456–468.]Search in Google Scholar
[37. Benowitz, N.L.: Clinical pharmacology of transdermal nicotine; Eur. J. Pharm. Biopharm. 41 (1995) 168–174.]Search in Google Scholar
[38. Benowitz, N.L., H. Porchet, L. Sheiner, and P. Jacob III: Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum; Clin. Pharmacol. Ther. 44 (1988) 23–28.]Search in Google Scholar
[39. Russel, M.A.H., M.J. Jarvis, G. Devitt, and C. Feyerabend: Nicotine intake by snuff users; Brit. Med. J. 283 (1981) 814–817.]Search in Google Scholar
[40. Guthrie, S.K., J.K. Zubieta, L. Ohl, L. Ni, R.A. Koeppe, S. Minoshima, E.F. Domino: Arterial/venous plasma nicotine concentrations following nicotine nasal spray; Eur. J. Clin. Pharmacol. 55 (1999) 639–643.]Search in Google Scholar
[41. Fant, R.V., L.L. Owen, and J.E. Henningfield: Nicotine replacement therapy; Prim. Care 26 (1999) 633–652.]Search in Google Scholar
[42 Fagerström, K.: Nicotine-replacement therapies; In: Nicotine and Public Health edited by R. Ferrence, J. Slade, R. Room and M. Pope; American Public Health Association, Washington, D.C. 2000.]Search in Google Scholar
[43. Holm, H., M.J. Jarvis, M.A. Russell, and C. Feyer-abend: Nicotine intake and dependence in Swedish snuff takers; Psychopharmacology 108 (1992) 507–511.]Search in Google Scholar
[44. Bhide, S.V., J. Nair, G.B. Maru, U.J. Nair, B.V. Kameshwar Rao, M.K. Chakraborty, and K.D. Brunne-mann: Tobacco-specific N-nitrosamines [TSNA] in green mature and processed tobacco leaves from India; Beitr. Tabakforsch. Int. 14 (1987) 29–32.]Search in Google Scholar
[45. Rathkamp, G., D. Chao, and D. Hoffmann: Analytical studies on nonvolatile N-nitrosamines in cigarette smoke; 27th TCRC, Winston-Salem, NC., October 3–5, 1973.]Search in Google Scholar
[46. Klus, H. and H. Kuhn: Untersuchungen über die nichtflüchtigen N-Nitrosamine der Tabakalkaloide [Investigations concerning the non-volatile N-nitros-amines of the tobacco alkaloids]; Fachl. Mitt. Austria Tabakwerke A.G., 16 (1975) 307–317.]Search in Google Scholar
[47. Bush, L.P., M. Cui, H. Shi, H.R. Burton, F.F. Fannin, L. Lei, and N. Due: Formation of tobacco-specific nitrosamines in air cured tobacco; Rec. Adv. Tob. Sci. 27 (2001) 23–46.]Search in Google Scholar
[48. DeRoton, C., A. Wiernik, I Wahlberg, and B. Vidal: Factors influencing the formation of tobacco-specific nitrosamines in French air-cured tobaccos in trials and at the farm level; Beitr. Tabakforsch. Int. 21 (2005) 305–320.]Search in Google Scholar
[49. Staaf, M., S. Back, A. Wiernik, I. Wahlberg, R.C. Long, and J.H. Young: Formation of tobacco-specific nitros-amines (TSNA) during air-curing: Conditions and control; Beitr. Tabakforsch. Int. 21 (2005) 321–330.]Search in Google Scholar
[50. Peele, D.M., M.G. Riddick, M.E. Edwards, J.S. Gentry, and T.B. Nestor: Formation of tobacco-specific nitros-amines in flue-cured tobacco; Rec. Adv. Tob. Sci. 27 (2001) 3–12.]Search in Google Scholar
[51. International Agency on Research on Cancer, Lyon, France: IARC monographs on the evaluation of carcino-genic risk to humans Vol.37: Tobacco habits other than smoking; Betel-quid and areca-nut chewing and some related nitrosamines. Lyon, 1985]Search in Google Scholar
[52. International Agency on Research on Cancer, Lyon, France: IARC monographs on the evaluation of carcino-genic risk to humans Suppl. 7: Overall evaluations of Carcinogenicity: an updating of IARC monographs 1 to 42. Lyon, 1987]Search in Google Scholar
[53. International Agency on Research on Cancer, Lyon, France: IARC monographs on the evaluation of carcinogenic risk to humans. Vol 89: Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC, Lyon, France, 2007.]Search in Google Scholar
[54. Hoffmann D., J.D. Adams, K.D. Brunnemann, and S.S. Hecht: Assessment of tobacco specific N-nitrosamines in tobacco products; Cancer Res. 39 (1979) 2505–2509.]Search in Google Scholar
[55. Hoffmann, D. and J.D. Adams: Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers; Cancer Res. 41 (1981) 4305–4308.]Search in Google Scholar
[56. Hoffmann D., N.H. Harley, I. Fisenne, J.D. Adams, and K.D. Brunnemann: Carcinogenic agents in snuff; J. Natl. Cancer Inst. 76 (1986) 435–437.]Search in Google Scholar
[57. Hoffmann D., J.D. Adams, D. Lisk, I. Fisenne, and K.D. Brunnemann: Toxic and carcinogenic agents in dry and moist snuff; J. Natl. Cancer Inst. 79 (1987) 1281–1286.]Search in Google Scholar
[58. Hoffmann D., K.D. Brunnemann, and S. Venitt: Car-cinogenic nitrosamines in oral snuff - Letter to the editor; Lancet 1 (1988) 1232]Search in Google Scholar
[59. Brunnemann, K.D., L. Genoble, and D. Hoffmann: N-nitrosamines in chewing tobacco: an international com-parison; J. Agric. Food Chem. 33 (1985) 1178–1181.]Search in Google Scholar
[60. Brunnemann, K.D., A. Rivenson, J.D. Adams, S.S. Hecht, and D. Hoffmann: A study of snuff carcino-genesis; in: Bartsch, H., i.K. O'Neill and R. Schulte-Hermann: Relevance of N-nitroso compounds to human Cancer, IARC Scientific publications, Lyon, France, 84 (1987) 456–459.]Search in Google Scholar
[61. Djordjevic, M.V., K.D. Brunnemann, and D. Hoffmann: Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco; Carcinogenesis 10 (1989) 1725–1731.]Search in Google Scholar
[62. Chamberlain, W.J., W.S. Schlotzhauer, and O.T. Chortyk: Chemical composition of nonsmoking tobacco products; J. Agric. Food Chem. 36 (1988) 48–50.]Search in Google Scholar
[63. Djordjevic, M.V., K.D. Brunnemann, and D. Hoffmann: The need for regulation of carcinogenic N-nitrosamines in oral snuff; Food Chem. Toxicol. 31 (1993) 497–501.]Search in Google Scholar
[64. Brunnemann, K.D., J. Qi, and D. Hoffmann: Chemical profile of two types of oral snuff tobacco; Food Chem. Toxicol. 40 (2002) 1699–1703.]Search in Google Scholar
[65. Hoffmann, D., M.V. Djordjevic, J. Fan, E. Zang, T. Glynn, and G.N. Connolly: Five leading U.S. com-mercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines; J. Natl. Cancer Inst. 87 (1995) 1862–1869.]Search in Google Scholar
[66. Jansson, C., A. Paccou, and B.-G. Österdahl: Analysis of tobacco specific N-nitrosamines in snuff by ethyl acetate extraction and liquid chromatographytandem mass spectrometry; J. Chromat. A 1008 (2003) 135-143.]Search in Google Scholar
[67. Stepanov, I., J. Jensen, D. Hatsukami, and S.S. Hecht: Tobacco-specific nitrosamines in new tobacco products; Nicotine Tob. Res. 8 (2006) 309–313.10.1080/14622200500490151]Search in Google Scholar
[68. Österdahl, B.-G., C. Jansson, and A. Paccou: Decreased levels of tobacco specific N-nitrosamines in moist snuff on the Swedish market; J Agric. Food Chem. 52 (2004) 5085–5088.]Search in Google Scholar
[69. Rickert, W.S., P.J. Joza, A.H. Trivedi, R.A. Momin, W.G. Wagstaff, and J.H. Lauterbach: Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market; Regul. Toxicol. Pharmacol. 53 (2009) 121–133.]Search in Google Scholar
[70. Pöschl, E.: 2004, unpublished results.]Search in Google Scholar
[71. Brunnemann, K.D. and D. Hoffmann: Chemical com-position of smokeless tobacco products; in: Smokeless tobacco or health. An international perspective (Smoking and Tobacco Control Monograph No.2; NIH Publ. No. 93-34-61), Bethesda, MD, National Cancer Institute, 1992. Pp. 96–108.]Search in Google Scholar
[72. Pöschl E.: 2008, unpublished results.]Search in Google Scholar
[73. Curvall, M., L. Romert, E. Norlén, and C.R. Enzell: Mutagen levels in urine from snuff users, cigarette smokers and non tobacco users–A comparison; Mut. Res. 188 (1987) 105–110.]Search in Google Scholar
[74. Jansson, T., L. Romert, J. Magnussonm, and D. Jenssen: Genotoxicity testing of extracts of a Swedish moist oral snuff; Mut. Res. 261 (1991) 101–115.]Search in Google Scholar
[75. Health Canada: Bacterial reverse mutation assay for mainstream tobacco smoke; Official Method T-501, second Ed., 2004.]Search in Google Scholar
[76. Health Canada: Neutral red uptake assay for mainstream tobacco smoke; Official Method T-502, second Ed., 2004.]Search in Google Scholar
[77. Health Canada: In vitro micronucleus assay for main-stream tobacco smoke; Official Method T-503, second Ed., 2004.]Search in Google Scholar
[78. Rickert, W.S., W.G. Wright, A.H. Trivedi, R.A. Momin, and J.H. Lauterbach: A comparative study of the mutagenicity of various types of tobacco products; Regul. Toxicol. Pharmacol. 48 (2007) 320–330.]Search in Google Scholar
[79. Critchley, J.A. and B. Unal: Health effects associated with smokeless tobacco: a systematic review; Thorax 58 (2003) 435–433.]Search in Google Scholar
[80. Roth, H.D., A.B. Roth, and X. Lui: Health risks of smoking compared to Swedish snus; Inhal. Toxicol. 17 (2005) 741–748.]Search in Google Scholar
[81. Broadstock, M.: Sytematic review of the health effects of modified smokeless tobacco products; NZHTA Report Vol. 10, 2007.]Search in Google Scholar
[82. Nitzkin, J.L. and B. Rodu: AAPHP Resolution and White Paper: The case for harm reduction for control of tobacco-related illness and death; American Association of Public Health Physicians. October 26, 2008.]Search in Google Scholar
[83. Boffetta, P., S.S. Hecht, N. Gray, P. Gupta, and K. Straif: Smokeless tobacco and cancer;Lancet Oncol. 9 (2008) 667–675.10.1016/S1470-2045(08)70173-6]Search in Google Scholar
[84. Lee, P.N. and J. Hamling: The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews; BMC Cancer 9 (2009) 256.]Search in Google Scholar
[85. Lee, P.N. and J.S. Hamling: Systematic review of the relation between smokeless tobacco and cancer in Europe and North America; BMC Medicine 7 (2009) 36.]Search in Google Scholar
[86. Luo, J., W. Ye, K. Zendehdel, J. Adami, H.-O. Adami, P. Boffetta, and O. Nyrén: Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study; Lancet 369 (2007) 2015–2020.]Search in Google Scholar
[87. Boffetta, P., B. Aagnes, E. Weiderpass, and A. Andersen: Smokeless tobacco use and the risk of cancer of the pancreas and other organs; Int. J. Cancer 114 (2005) 992–995.]Search in Google Scholar
[88. Zendehdel, K., O. Nyrén, J. Luo, P.W. Dickman, P. Boffetta, A. Englund, and W. Ye: Risk of gastroesopha-geal cancer among smokers and users of Scandinavian moist snuff; Int. J. Cancer 122 (2008) 1095–1099.]Search in Google Scholar
[89. Wynder, E.L., I.J. Bross, and R.M. Feldman: A study of the etiologic factors in cancer of the mouth; Cancer 10 (1957) 1300–1323.]Search in Google Scholar
[90. Winn D.M., W J. Blot, C.M. Shy, L.W. Pickle, A. Toledo, and J.F. Fraumeni Jr: Snuff dipping and oral cancer among women in the southern United States; New Engl. J. Med. 304 (1981) 745–749.]Search in Google Scholar
[91. Mashberg A., P. Boffetta, R. Winkelman, and L. Garfinkel: Tobacco smoking, alcohol drinking and cancer of the oral cavity and oropharynx among U.S. veterans; Cancer 72 (1993) 1369–1375.]Search in Google Scholar
[92. Bouquot, J.E. and R. L. Meckstroth: Oral cancer in a tobacco-chewing US population – no apparent increased incidence or mortality; Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 86 (1998) 697–706.10.1016/S1079-2104(98)90207-4]Search in Google Scholar
[93. Schildt, E.B., M. Eriksson, L. Hardell, and A. Magnuson: Oral snuff, smoking habits and alcohol con-sumption in relation to oral cancer in a Swedish case-control study; Int. J. Cancer 77 (1998) 341–346.]Search in Google Scholar
[94. Lewin, F., S.E. Norell, H. Johansson, P. Gustavsson, J. Wennerberg, A. Biörklund, and L. E. Rutqvist: Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck. A population-based case-referent study in Sweden; Cancer 82 (1998) 1367–1375.]Search in Google Scholar
[95. Rosenquist, K., J. Wennerberg, E.-B. Schildt, A. Bladström, B.G. Hansson, and G. Andersson: Use of Swedish moist snuff, smoking and alkohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden; Acta Oto-Laryngol. 125 (2005) 991–998.]Search in Google Scholar
[96. Accortt, N.A., J.W. Waterbor, C. Beall, and G. Howard: Chronic disease mortality in a cohort of smokeless tobacco users; Am. J. Epidemiol. 156 (2002) 730–737.]Search in Google Scholar
[97. Rodu, B. and P. Cole: Smokeless tobacco use and cancer of the upper respiratory tract; Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93 (2002) 511–515.10.1067/moe.2002.123497]Search in Google Scholar
[98. Weitkunat, R., E. Sander, and P.N. Lee: Meta-analysis of the relation between European and American smokeless tobacco and oral cancer; BMC Public Health 7 (2007) 334.]Search in Google Scholar
[99. Conway, D.: Oral cancer risk and smokeless tobacco products – clouded by smoke? Evid. Based Dent. 9 (2008) 114–115]Search in Google Scholar
[100. Roosaar, A., A.L.V. Johansson, G. Sandborgh-Englund, T. Axéll, and O. Nyrén: Cancer and mortality among users and nonusers of snus; Int. J. Cancer 123 (2008)168–173.]Search in Google Scholar
[101. Pichler, K: Typische Pigmentierung der Wangen-schleimhaut bei Tabak-Kauern [Typical pigmentation oft he cheek mucosa of tobacco chewers]; Wiener Med. Wchnschr. 6 (1916).]Search in Google Scholar
[102. Bouquot, J.E. and R.J. Gorlin: Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years; Oral Surg. Oral Med. Oral Pathol. 61 (1986) 373–381.]Search in Google Scholar
[103. Grady, D., J. Greene, T.E. Daniels, V.L. Ernster, P.B. Robertson, W. Hauck, D. Greenspan, J. Greenspan, and S. Silverman Jr: Oral mucosal lesions found in smoke-less tobacco users; J. Am. Dent. Assoc. 121 (1990) 117–123.]Search in Google Scholar
[104. Sinusas, K., J.G. Coroso, M.D. Sopher, and B.F. Carbtree: Smokeless tobacco use and oral pathology in a professional baseball organization; J. Fam. Pract. 34 (1992) 713–718.]Search in Google Scholar
[105. Greer Jr, R.O. and T.C. Poulson: Oral tissue alterations associated with the use of smokeless tobaccos by teen-agers – Part 1. Clinical findings; Oral Surg. Oral Med. Ora Pathol. 56 (1983) 275–284.]Search in Google Scholar
[106. Greer, R.O., T.C. Poulson, M.E. Boone, J.E. Lindenmuth, and L. Crosby: Smokeless tobacco-asso-ciated oral changes in juvenile, adult and geriatric patients: clinical and histomorphologic features; Gero-dontics 2 (1986) 87–98.]Search in Google Scholar
[107. Greene, J.C., V.L. Ernster, D.G. Grady, P.B. Robertson, M.M. Walsh, and L.A. Stillmann: Oral mucosal lesions: clinical findings in relation to smokeless tobacco use among US baseball players; Monograph. 2. Smokeless tobacco or health, an international perspective; NIH publication No. 93-4361 (1993) 41–50.]Search in Google Scholar
[108. Andersson, G. and T. Axéll: Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study; J. Oral Pathol. Med. 18 (1989) 2–7.]Search in Google Scholar
[109. Roosaar, A., A.L.V. Johansson, G. Sandborg-Englund, O. Nyrén, and T. Axéll: A long term follow-up study on the natural course of snus-induced lesions among Swedish snus users; Int. J. Cancer 119 (2006) 392–397.]Search in Google Scholar
[110. Kallischnigg, G., R. Weitkunat, and P.N. Lee: Syste-matic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States; BMC Oral Health 8 (2008) 13.]Search in Google Scholar
[111. Brinton L.A., W.J. Blot, J.A. Becker, D.M. Winn, J.P. Browder, J.C. Farmer Jr, and J.F. Fraumeni Jr: A case-control study of cancers of the nasal cavity and paranasal sinuses; Am. J. Epidemiol. 119 (1984) 896–906.]Search in Google Scholar
[112. Sapundzhiev, N. and J.A. Werner: Nasal snuff: historical review and health related aspects; J. Laryngol. Otol.117 (2003) 686–691.]Search in Google Scholar
[113. Pfaue D., M. Tisch, and H. Maier: Krebs durch Schnupftabak? [Cancer by the use of nasal snuff]; HNO 51 (2003) 193–196.]Search in Google Scholar
[114. Lagergren, J., R. Bergström, A. Lindgren, and O. Nyrén: The role of tobacco, snuff and alcohol use in the aetiology of cancer oft the oesophagus and gastric cardia; Int. J. Cancer 85 (2000) 340–346.]Search in Google Scholar
[115. Ye, W., A.M. Ekström, L.-E. Hansson, R. Bergström, and O. Nyrén: Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type; Int. J. Cancer 83 (1999) 223–229.]Search in Google Scholar
[116. Alguacil J. and D.T. Silverman: Smokeless and other non-cigarette tobacco use and pancreatic cancer: A case-control study based on direct interviews; Cancer Epidemiol. Biomarkers Prev. 13 (2004) 55–58.]Search in Google Scholar
[117. Nilsson, R.: Possible carcinogenicity of smokeless tobacco–Letter to the Editor; Int. J. Cancer 118 (2006) 1582–1583.]Search in Google Scholar
[118. Rutqvist, L.E. and F. Lewin: Flawed methods–Letter to the Editor; Int. J. Cancer 118 (2006) 1581.]Search in Google Scholar
[119. Ramström, L.: Re: “Smokeless tobacco use and risk of cancer of the pancreas and other organs” by Boffetta et al. - Letter to the Editor; Int. J. Cancer 118 (2006) 1584.]Search in Google Scholar
[120. Rodu, B. and P. Cole: A deficient study of smokeless tobacco use and cancer - Letter to the Editor; Int. J. Cancer 118 (2006) 1585.]Search in Google Scholar
[121. Hassan, M.M., J.L. Abbruzzese, M.L. Bondy, R.A. Wolff, J.-N. Vauthey, P.W. Pisters, D.B. Evans, R. Kahn, R. Lenzi, L. Jiao, and D. Li: Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: A case-control study; Cancer 109 (2007) 2547–2556.]Search in Google Scholar
[122. Sponsiello-Wang, Z., R. Weitkunat, and P.N. Lee: Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America; BMC Cancer 8 (2008) 356.]Search in Google Scholar
[123. Accortt, N.A., J.W. Waterbor, C. Beall, and G. Howard: Cancer incidence among a cohort of smokeless tobacco users (United States); Cancer Causes Control 16 (2005) 1107–1115.]Search in Google Scholar
[124. Henley, S.J., M.J. Thun, C. Connell, and E.E. Calle: Two large prospective studies of mortality among men who used snuff or chewing tobacco (United States); Cancer Causes Control 16 (2005) 347–358.]Search in Google Scholar
[125. Foulds, J. and L. Ramström: Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II?–Letter to the Editor; Cancer Causes Control 17 (2006) 227–228.]Search in Google Scholar
[126. Hecht, S.S.: Letter to the editor, response to J. Foulds and L. Ramström; Cancer Causes and Control 17 (2006) 227–228 and to S.J. Henley, M.J. Thun, C. Connell, and E.E. Calle; Cancer Causes and Control 16 (2005) 347-358 (2005). How smokeless tobacco can cause lung cancer; Cancer Causes Control 17 (2006) 859–860.]Search in Google Scholar
[127. Henley, S.J. and M.J. Thun: Letter to the editor, response to J. Foulds and L. Ramström: Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II; Cancer Causes Control 17 (2006) 857–858.]Search in Google Scholar
[128. Lee, P.N.: Circulatory disease and smokeless tobacco in Western populations: a review of the evidence; Int. J. Epidemiol. 36 (2007) 789–804.]Search in Google Scholar
[129. Hergens, M.P., M. Lambe, G. Pershagen, and W. Ye: Risk of hypertension amongst Swedish male snuff users: a prospective study; J. Intern. Med. 264 (2008) 187–194.]Search in Google Scholar
[130. Gupta, R., H. Gurm, and J. R. Bartholomew: Smokeless tobacco and cardiovascular risk; Arch. Intern. Med. 164 (2004) 1845–1849.]Search in Google Scholar
[131. Arabi, Z.: Metabolic and cardiovascular effects of smokeless tobacco: J. Cardiometab. Syndr. (JCMS) 1 (2006) 345–350.]Search in Google Scholar
[132. Bolinder, G., L. Alfredsson, A. Englund, and U. de Faire: Smokeless tobacco use and increased cardiovas-cular mortality among Swedish construction workers; Am. J. Public Health 84 (1994) 399–404.]Search in Google Scholar
[133. Rodu, B. and P. Cole: Excess mortality in smokeless tobacco users not meaningful. Am. J. Public Health 85 (1995) 118–119.]Search in Google Scholar
[134. Hergens, M.P., A. Ahlbom, T. Andersson, and G. Pershagen: Swedish moist snuff and myocardial infarction among men; Epidemiology 16 (2005) 12–16.]Search in Google Scholar
[135. Ahlbom, A., U.A. Olsson, and G. Pershagen: Hälso-risker med Snus [Health Risks by Snuff] Position paper; Stockholm: Swedish National Board of Health and Wellfare; 1997.]Search in Google Scholar
[136. Hergens, M.P., L. Alfredsson, G. Bolinder, M. Lambe, G. Pershagen, and W. Ye: Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men; J. Intern. Med. 262 (2007) 351–359, Erratum: ibid. p. 590.]Search in Google Scholar
[137. Huhtasaari, F., K. Asplund, V. Lundberg, B. Stegmayr, and P.O. Wester: Tobacco and myocardical infarction: is snuff less dangerous than cigarettes? Brit. Med. J. 305 (1992) 1252–1256.]Search in Google Scholar
[138. Huhtasaari, F., V. Lundberg, M. Eliasson, U. Janlert, and K. Asplund: Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men; J. Am. Coll. Cardiol. 34 (1999) 1784–1790.]Search in Google Scholar
[139. Asplund, K., S. Nasic, U. Janlert, and B. Stegmayr: Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study; Stroke 34 (2003) 1754–1759.]Search in Google Scholar
[140. Johansson, S.E., K. Sundquist, J. Qvist, and J. Sundquist: Smokeless tobacco and coronary heart disease: a 12-year follow-up study; Eur. J. Cardiovasc. Prev. Rehabil. 12 (2005) 387–392.]Search in Google Scholar
[141. Haglund, B., M. Eliasson, M. Stenbeck, and M. Rosén: Is moist snuff associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden; Scand. J. Public Health 35 (2007) 618–622.]Search in Google Scholar
[142. Wennberg, P., M. Eliasson, G. Hallmans, L. Johansson, K. Boman, and J.-H. Jansson: The risk of myocardial infarction and sudden cardic death amongst snuff users with or without a previous history of smoking; J. Intern. Med. 262 (2007) 360–367.]Search in Google Scholar
[143. Hergens, M.P., M. Lambe, G. Pershagen, A. Terent, and W. Ye: Smokeless tobacco and the risk of stroke; Epidemiology 19 (2008) 794–799.]Search in Google Scholar
[144. Mushtaq, N., D.M. Thompson, J. Morris, W.L. Owen, and V.J. Skaggs: Smokeless tobacco and risk of cardiovascular disease; APHA Scientific Session, Boston MA, November 4–8, 2006.]Search in Google Scholar
[145. Asplund, K: Smokeless tobacco and cardiovascular disease; Progr. Cardiovasc. Dis. 45 (2003) 383–394.10.1016/S0033-0620(03)80002-6]Search in Google Scholar
[146. Critchley, J.A. and B. Unal: Is smokeless tobacco a risk factor for coronary heart diseases? A systematic review of epidemiological studies; Europ. J. Cardiovas, Prev. Rehab. 11 (2004) 101–112.]Search in Google Scholar
[147. Hirsch, J.-M., J. Hedner, L. Wernstedt, J. Lundberg, and T. Hedner: Hemodynamic effects of the use of snuff; Clin. Pharmacol. Ther. 52 (1992) 394–401.10.1038/clpt.1992.161]Search in Google Scholar
[148. Bolinder, G.M., B.O. Ahlborg, and J.H. Lindell: Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey; J. Intern. Med. 232 (1992) 327–334.]Search in Google Scholar
[149. Ekenvall, L. and L.E. Lindblad: Vibrationsutlösta Raynaudfenomen och nicotinkonsumation–en preliminär rapport [Vibration induced white fingers and nicotine–a preliminary report]; Opusc. Med. 30 (1985) 28–31.]Search in Google Scholar
[150. Boffetta, P. and K. Straif: Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis; Brit. Med. J. 339 (2009) b3060, doi: 10.1136/bmj.b3060 (published 18 August 2009)10.1136/bmj.b3060]Search in Google Scholar
[151. Koskinen, L.-O.D. and P.C. Blomstedt: Smoking and non-smoking tobacco as risk factors in subarachnoid haemorrhage; Acta Neurol. Scand. 114 (2006) 33-37.]Search in Google Scholar
[152. Persson, P.-G., G. Hellers, and A. Ahlbom: Use of oral moist snuff and inflammatory bowel disease; Int. J. Epidemiol. 22 (1993) 1101–1103.]Search in Google Scholar
[153. Elliasson, M., K. Asplund, S. Nasic, and B. Rodu: Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study; J. Intern. Med. 256 (2004) 101–110.]Search in Google Scholar
[154. Fernberg, P., A. Odenbro, R. Bellocco, P. Boffetta, Y. Pawitan, and J. Adami: Tobacco use, body mass index and the risk of malignant lymphomas–a nationwide cohort study in Sweden; Int. J. Cancer 118 (2006) 2298–2302.]Search in Google Scholar
[155. Norberg, M., H. Stenlund, B. Lindahl, K. Boman, and L. Weinehall: Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep's clothing? Scand. J. Public Health 34 (2006) 576–583.]Search in Google Scholar
[156. Wändell, P.E., G. Bolinder, U. de Faire, and M.-L. Hellénius: Association between metabolic effects and tobacco use in 60-year-old Swedish men; Eur. J. Epidemiology 23 (2008) 431–434.]Search in Google Scholar
[157. Fang, R., R. Bellocco, M.A. Hernán, and W. Ye: Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis–a prospective cohort study; Neuro-epidemiology 27 (2006) 217–221.]Search in Google Scholar
[158. England, L.J., R.J. Levine, J.L. Mills, M.A. Klebanoff, K.F. Yu, and S. Cnattingius: Adverse pregnancy outcomes in snuff users; Am. J. Obstet. Gynecol. 189 (2003) 939–943.10.1067/S0002-9378(03)00661-6]Search in Google Scholar
[159. Nilsson R.: A qualitative and quantitative risk assessment of snuff dipping; Regul. Toxicol. Pharmacol. 28 (1998) 1–16.10.1006/rtph.1998.12299784428]Search in Google Scholar
[160. Hecht S.S., A. Rivenson, J. Braley, J. DiBello, J.D. Adams, and D. Hoffmann: Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff; Cancer Res. 46 (1986) 4162–4166.]Search in Google Scholar
[161. Rivenson, A., D. Hoffmann, B. Prokopczyk, S. Amin, and S.S. Hecht: Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines; Cancer Res. 48 (1988) 6912–6917.]Search in Google Scholar
[162. Hecht, S.S., S.G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D.K. Hatsukami: Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users; Cancer Epidemiol. Biomarkers Prev. 17 (2008) 732–735.]Search in Google Scholar
[163. Kresty, L.A., S.G. Carmella, A. Borukhova, S.A. Akerkar, R. Gopalakrishnan, R.E. Harris, G.D. Stoner, and S.S. Hecht: Metabolites of a tobacco specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia; Cancer Epidemiol. Biomarkers Prev. 5 (1996) 521–525.]Search in Google Scholar
[164. Hecht, S.S., S.G. Carmella, S.E. Murphy, W.T. Riley, C. Le, X. Luo, M. Moony, and D.K. Hatsukami: Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers; Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1567–1572.]Search in Google Scholar
[165. Hatsukami, D.K., C. Lemmonds, Y Zhang, S.E. Murphy, C. Le, S.G. Carmella, and S.S. Hecht: Evaluation of carcinogen exposure in people who used “reduced exposure” tobacco products; J. Natl. Cancer Inst. 96 (2004) 844–852.]Search in Google Scholar
[166. British Thoracic Society: Smoking withdrawal in hospital patients: Factors associated with outcome; Thorax 39 (1984) 651–656.]Search in Google Scholar
[167. British Thoracic Society, Research Commettee: Smoking cessation in patients: two further studies by the British Thoracic Society; Thorax 45 (1990) 835–840.]Search in Google Scholar
[168. Cahill, K., L. Stead, and T. Lancaster: A preliminary benefit-risk assessment of varenicline in smoking cessation; Drug Saf. 32 (2009) 119–135.]Search in Google Scholar
[169. Jansson T., L. Romert, J. Magnusson, and D. Jenssen: Genotoxicity testing of extracts of a Swedish moist oral snuff; Mutat. Res. 261 (1991) 101–115.]Search in Google Scholar
[170. Brown B.G., A.J. Borschke, and D.J. Doolittle: An analysis of the role of tobacco-specific nitrosamines in the carcinogenicity of tobacco smoke; Nonlinearity Biol. Toxicol. Med. 1 (2003) 179–198.]Search in Google Scholar
[171. Enzell, C.R.: Terpenoid components in leaf and their relationship to smoking quality and aroma; Rec. Adv. Tob. Sci. 2 (1976) 32–60.]Search in Google Scholar
[172. Garewal, H.: Antioxidants in oral cancer prevention; Am. J. Clin. Nutr. 62 (1995) 1410S–1416S.]Search in Google Scholar
[173. Garewal H.S., R.V. Katz, F. Meyskens, J. Pitcock, D. Morse, S. Friedman, Y. Peng, D.G. Pendrys, S. Mayne, D. Alberts, T. Kierschk, and E. Graver: $-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial; Arch. Otolaryngol. Head Neck Surg. 125 (1999) 1305–1310.]Search in Google Scholar
[174. Wahlberg, I. and T. Ringberger: Smokeless tobacco; In: World Agriculture Series; edited by D.L. Davis and M.T. Nielsen, Tobacco Production, Chemistry and Technology. Blackwell Science, London, 1999, pp. 452–460.]Search in Google Scholar
[175. Kallianos, A.G.: Phenolics and acids in leaf and their relationship to smoking quality and aroma; Rec. Adv. Tob. Sci. 2 (1976) 61–79.]Search in Google Scholar
[176. Chung, F-L., M.A. Morse, K.I. Eklind, and Y. Xu: Inhibiton of the tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea; Ann. N. Y. Acad. Sci. 686 (1993) 186–201.]Search in Google Scholar
[177. Yang, C.S., G.Y. Yang, J.M. Landau, S. Kim, and J. Liao: Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression; Exp. Lung Res. 24 (1998) 629–639.]Search in Google Scholar
[178. Rodu B. and B. Ou: The antioxidant properties of tobacco; Tobacco Science 44 (2000) 71–73.]Search in Google Scholar
[179. Prior, R.L. and G. Cao: Analysis of botanicals and dietary supplements for antioxidant capacity: a review; J. Assoc. Off. Anal. Chem. Int. 83 (2000) 950–956.]Search in Google Scholar
[180. Li Q., M. Krauss, M. Maher, G. Bokelman, and F. Gadani: Reduction of tobacco specific nitrosamines (TSNAs) by increasing endogenous antioxidants in Burley tobaccos: a review of results from field experiments; in: 57th Tobacco Chemists Research Conference, Raleigh, NC, 2003.]Search in Google Scholar
[181. Ahlbom A., U.A. Olsson, and G. Pershagen: Health hazards of moist snuff; National Board on Health and Welfare. Stockholm, Sweden, 1997.]Search in Google Scholar
[182. Savitz, D.A., R.E. Meyer, J.M. Tanzer, S.S. Mirvish, and F. Lewin: Public health implications of smokeless tobacco use as a harm reduction strategy; Am. J. Publ. Health 96 (2006) 1934–1939.]Search in Google Scholar
[183. Tso, T.C., N. Harley, and L. Alexander: Source of lead-210 and polonium-210 in tobacco; Science 153 (1966) 880–882.]Search in Google Scholar
[184. Lugon-Moulin, N., M. Zang, F. Gadani, L. Rossi, D. Koller, M. Krauss, and G.J. Wagner: Critical review of the science and options for reducing cadmium in tobacco (Nicotiana tabacum L.) and other plants; Adv. Agron. 83 (2004) 111–180.]Search in Google Scholar
[185. Idris, A.M., S.O. Ibrahim, E.N. Vasstrand, A.C. Johannessen, J. R. Lillehaug, B. Magnusson, M. Wall-ström, J.M. Hirsch, and R. Nilsen: The Swedish snus and the Sudanese toombak: are they different? Oral Oncol. 34 (1998) 558–566.]Search in Google Scholar
[186. Rodu, B., B. Stegmayr, S. Nasic, and K. Asplund: Im-pact of smokeless tobacco use on smoking in northern Sweden; J. Intern. Med. 252 (2002) 398–404.]Search in Google Scholar
[187. Rodu, B., B. Stegmayr, S. Nasic, P. Cole, and K. Asplund: Evolving patterns of tobacco use in northern Sweden. J. Intern. Med. 253 (2003) 660 – 665.]Search in Google Scholar
[188. Stegmayr, B., M. Eliasson, and B. Rodu: The decline of smoking in Northern Sweden. Scand. J. Public Health, 33 (2005) 321–324.10.1080/1403494051003230116087495]Search in Google Scholar
[189. Gilljam H. and M.R. Galanti: Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden; Addiction 98 (2003) 1183-1189.]Search in Google Scholar
[190. Ramström, L.M. and J. Foulds: Role of snus in initiation and cessation of tobacco smoking in Sweden; Tob. Control 15 (2006) 210–214.]Search in Google Scholar
[191. Tomar, S.L.: Snuff use and smoking in U.S. men. Implications for harm reduction; Am. J. Prev. Med. 23 (2002) 143–149.]Search in Google Scholar
[192. Lundqvist, G., H. Sandström, A. Öhman, and L. Weinehall: Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population; Scand. J. Public Health 37 (2009) 161–167.]Search in Google Scholar
[193. Furberg, H., P. Lichtenstein, N.L. Pedersen, C. Bulik, and P.F. Sullivan: Cigarettes and oral snuff use in Sweden: prevalence and transitions; Addiction 101 (2006) 1509–1515.]Search in Google Scholar
[194. Lindström M.: Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden; Tob. Control: 16 (2007) 410–416.]Search in Google Scholar
[195. Galanti, M.R., I. Rosendahl, and S. Wickholm: The development of tobacco use in adolescence among “snus starters” and “cigarette starters”: An analysis of the Swedish “BROMS” cohort; Nicotine Tob. Res. 10 (2008) 315–323.]Search in Google Scholar
[196. Lund, K.E., E.M. Tefre, A. Amundsen, and S. Nordlund: Røyking, bruk av snus og annen risikoatferd blant studenter [Cigarette smoking, use of snuff and other risk behavior among students]; Tidssrk. Nor. Legeforen 128 (2008) 1808–1811.]Search in Google Scholar
[197. Zhu, S.-H., J. B. Wang, A. Hartman, Y. Zhuang, A. Gamst, J.T. Gibson, H. Gilljam, and M.R. Galanti: Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob. Control 18 (2009) 82–87.]Search in Google Scholar
[198. Cobb, C.O., M.F. Weaver, and T. Eissenberg: Evalu-ating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers; Tob. Control, (2009), doi:10.1136/tc2008.028993 (published 2 April 2009).]Search in Google Scholar
[199. Stratton, K., P. Shetty, R. Wallace, and S. Bondurant: Clearing the smoke–Assessing the science base for tobacco harm reduction. National Academy of Science, Institute of Medicine; National Academy Press, Washington, D.C., 2001, pp.27–28.]Search in Google Scholar
[200. Bates, C., J. Britton, I. Campbell, T. Coleman, L. Cuthbertson, R. Edwards, C. Godfrey, K. Jamrozik, M. Jarvis, A. McNeill, D. Milner, and A. Woodcock: Protecting smokers, saving lives. Royal College of Physicians, London, 2002.]Search in Google Scholar
[201. Bates, C., K. Fagerström, M. Jarvis, M. Kunze, A. McNeill, and L. Ramström: European Union policy on smokeless tobacco: A statement in favor of evidence based regulation for public health; Tob. Control 12 (2003) 360–367.]Search in Google Scholar
[202. Levy, D.T., E.A. Mumford, K.M. Cummings, E.A. Gilpin, G. Giovino, A. Hyland, D. Sweanor, and K.E. Warner: The relative risk of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts; Cancer Epidemiol. Biomarkers Prevent. 13 (2004) 2035–2042.]Search in Google Scholar
[203. Rodu, B. and P. Cole: T.: The burden of mortality from smoking: Comparing Sweden with other countries in the European Union; Eur. J. Epidemiol. 19 (2004) 129–131.]Search in Google Scholar
[204. House Subcommittee on Commerce, Trade, and Consumer Protection, 3 June 2003; http//energy commerce.house.gov/reparchives/108/Hearings/06032003hearing928/hearing.htm]Search in Google Scholar
[205. Royal College of Physicians: Harm reduction in nicotine addiction. Helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians, RCP, London, 2007.]Search in Google Scholar
[206. Rodu, B. and W.T. Godshall: Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduction J. 3 (2006) 37.10.1186/1477-7517-3-37177927017184539]Search in Google Scholar
[207. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Health effects of smokeless tobacco products, Preliminary Report; 2007.]Search in Google Scholar
[208. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Health effects of smokeless tobacco products; 2008.]Search in Google Scholar
[209. Gartner, C.E., W.D. Hall, T. Vos, M.Y. Bertram, A.L. Wallace, and S.S. Lin: Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study; Lancet 369 (2007) 2010–2014.]Search in Google Scholar
[210. McKee, M., A. Gilmore and M. Lambe: Swedish snus for tobacco harm reduction – Letter to the editor; Lancet 370 (2007) 1206.]Search in Google Scholar
[211. Gartner, C.E., W.D. Hall, T. Vos, M.Y. Bertram, and A.L. Wallace: Swedish snus for tobacco harm reduction – Authors’ reply; Lancet 370 (2007) 1260–1261.]Search in Google Scholar
[212. Britton, J. and R. Edwards: Tobacco smoking, harm reduction, and nicotine product regulation; Lancet 371 (2008) 441–445.]Search in Google Scholar
